MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

11 Dec 2017 Evaluate

Alembic Pharmaceuticals has informed that their Associate Company, Rhizen Pharmaceuticals SA has released a Press Release announcing that the USFDA has granted Fast Track Designation for RP6530 (tenalisib).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..